| Literature DB >> 35068470 |
Leevi A Toivonen1, Heikki Mäntymäki1, Arja Häkkinen2, Hannu Kautiainen3, Marko H Neva1.
Abstract
STUDYEntities:
Mesh:
Year: 2022 PMID: 35068470 PMCID: PMC8772434 DOI: 10.1097/BRS.0000000000004242
Source DB: PubMed Journal: Spine (Phila Pa 1976) ISSN: 0362-2436 Impact factor: 3.468
Demographic Data, Self-reported (∗) Prevalence of Symptoms and Comorbidities and Questionnaires at the Baseline, and Type of Primary Surgery Divided by Surgical Indication (DLSD Includes Spinal Stenosis With or Without Degenerative Spondylolisthesis; “Other Reasons” Include Deformities, Postoperative Conditions After Decompression and Posttraumatic Conditions)
| IS, N = 64 | DLSD, N = 222 | Others, N = 79 | ||
| Women, n (%) | 28 (44) | 169 (76) | 44 (56) | <0.001 |
| Age, mean (SD) | 48 (12) | 65 (10) | 64 (12) | <0.001 |
| BMI, mean (SD) | 27.8 (4.3) | 28.4 (4.5) | 28.3 (4.1) | 0.49 |
| Smoking∗, n (%) | 7 (11) | 12 (6) | 8 (10) | 0.21 |
| Education years∗, mean (SD) | 13.1 (3.9) | 11.2 (3.9) | 11.0 (3.8) | 0.002 |
| Physical activity∗, h/wk, median (IQR) | 6.0 (3.0, 10.0) | 4.5 (2.0, 9.0) | 4.6 (2.0, 10.0) | 0.099 |
| Duration of spinal problem∗, yr, median (IQR) | 10.0 (5.0, 25.0) | 9.5 (4.0, 20.0) | 15.0 (5.0, 25.0) | 0.097 |
| Back pain∗, VAS, mean (SD) | 60 (25) | 62 (26) | 72 (22) | 0.005 |
| Leg pain∗, VAS, mean (SD) | 56 (26) | 67 (23) | 70 (24) | 0.001 |
| ODI∗, mean (SD) | 42 (15) | 46 (15) | 51 (18) | <0.001 |
| DEPS∗, mean (SD) | 9.2 (6.7) | 10.5 (6.0) | 10.9 (6.9) | 0.12 |
| Co-morbidities∗, n (%) | ||||
| Cardiovascular diseases | 22 (36) | 119 (58) | 43 (63) | 0.003 |
| Diabetes | 5 (8) | 24 (12) | 12 (18) | 0.25 |
| Mental disorders | 2 (3) | 5 (2) | 0 (0) | 0.36 |
| Lung diseases | 6 (10) | 12 (6) | 3 (4) | 0.41 |
| Neurological disorders | 2 (3) | 5 (2) | 0 (0) | 0.36 |
| Rheumatic diseases | 0 (0) | 1 4 (7) | 7 (10) | 0.029 |
| Fusion, n (%) | ||||
| Lower end vertebra | <0.001 | |||
| -L3 | 0 (0) | 1 (0) | 2 (3) | |
| -L4 | 1 (2) | 9 (4) | 3 (4) | |
| -L5/6 | 10 (16) | 117 (53) | 27 (34) | |
| -S1 | 53 (83) | 95 (43) | 47 (59) | |
| Length, levels, n (%) | <0.001 | |||
| 1 | 36 (56) | 61 (27) | 8 (10) | |
| 2 | 21 (33) | 89 (40) | 22 (28) | |
| 3 | 7 (11) | 54 (24) | 30 (38) | |
| 4 | 0 (0) | 17 (8) | 11 (14) | |
| 5 | 0 (0) | 1 (0) | 8 (10) | |
| Interbody cage (TLIF/PLIF), n (%) | 35 (55) | 24 (11) | 7 (9) | <0.001 |
DEPS indicates Depression scale; DLSD, degenerative lumbar spine disease; IQR, interquartile range; IS, isthmic spondylolisthesis; ODI, Oswestry Disability Index; PLIF, posterior lumbar interbody fusion; SD, standard deviation; TLIF, transforaminal lumbar interbody fusion; VAS, visual analogue scale.
Self-reported.
The Crude Rate of Revisions for ASD During the Whole Follow-up Period in all Patients and Subgroups by Surgical Indication (DLSD Includes Spinal Stenosis With or Without Degenerative Spondylolisthesis; “Other Reasons” Include Deformities, Postoperative Conditions After Decompression and Posttraumatic Conditions)
| Indication for surgery | Rate of revision for ASD (%) | 95% CI (%) |
| All patients | 17.8 | 14.0 to 22.1 |
| • IS | 4.8 | 1.6 to 22.1 |
| • DLSD | 20.5 | 15.6 to 26.7 |
| • others | 20.6 | 12.9 to 31.9 |
ASD indicates adjacent segment disease; CI, confidence interval; DLSD, degenerative lumbar spine disease; IS, isthmic spondylolisthesis.
Figure 1The cumulative rate of revisions for adjacent segment disease (ASD) between groups of surgical indications adjusted by age, sex, fusion length and caudal end of fusion (“Isthmic” = isthmic spondylolisthesis (IS); “Degenerative” (DLSD) includes spinal stenosis with or without degenerative spondylolisthesis; “Others” include deformities, postoperative conditions after decompression and posttraumatic conditions).